Navigation Links
Thoratec Presentation at UBS Conference to be Webcast
Date:9/14/2009

PLEASANTON, Calif., Sept. 14 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that will be participating in the UBS Global Life Sciences Conference on Tuesday, September 22.

David V. Smith, executive vice president and chief financial officer, will provide an update on the company beginning at 11:30 a.m., Eastern Daylight Time (8:30 a.m., Pacific Daylight Time).

The presentation will be available through the conference website at http://cc.talkpoint.com/ubsx001/092109a_ke/?entity=57_02G520B, or on the company's website at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 14,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) Division is a leader in point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's websites at http://www.thoratec.com or http://www.itcmed.com.


'/>"/>
SOURCE Thoratec Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Thoratec Corporation and HeartWare International, Inc. Announce Termination of Proposed Transaction
2. Thoratec Schedules Second Quarter Conference Call, Webcast
3. Thoratec Announces Appointment of Paul LaViolette to Board of Directors
4. Thoratec Presentation at JMP Securities Conference to be Webcast
5. Thoratec Schedules First Quarter Conference Call, Webcast
6. Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission
7. Thoratec Presentation at Raymond James Conference to Be Webcast
8. Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;
9. Thoratec Reports 34 Percent Increase in 2008 Revenues
10. Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast
11. Thoratec Presentation at Piper Jaffary Conference to be Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... Park, KS (PRWEB) , ... June 27, 2016 , ... ... in retailers of Eyeglasses . , Millions of individuals in the United States ... eyeglasses have become a way to both correct vision and make a fashion statement. ...
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 ... appointment of Dr. Edward Futcher to ... Director, effective June 23, 2016.Dr. Futcher was also ... and Governance Committees.  As a non-executive member of ... expertise and strategic counsel to VolitionRx in connection ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
Breaking Medicine Technology: